150 related articles for article (PubMed ID: 1723762)
1. Endothelium-derived nitric oxide as a mediator of acetylcholine-induced coronary vasodilation in dogs.
Ishizaka H; Okumura K; Yamabe H; Tsuchiya T; Yasue H
J Cardiovasc Pharmacol; 1991 Nov; 18(5):665-9. PubMed ID: 1723762
[TBL] [Abstract][Full Text] [Related]
2. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis.
Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G
J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898
[TBL] [Abstract][Full Text] [Related]
3. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
4. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart.
Quyyumi AA; Dakak N; Andrews NP; Gilligan DM; Panza JA; Cannon RO
Circulation; 1995 Aug; 92(3):320-6. PubMed ID: 7634444
[TBL] [Abstract][Full Text] [Related]
5. Effect of an arginine analogue on acetylcholine-induced coronary microvascular dilatation in dogs.
Komaru T; Lamping KG; Eastham CL; Harrison DG; Marcus ML; Dellsperger KC
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2001-7. PubMed ID: 1750548
[TBL] [Abstract][Full Text] [Related]
6. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia.
Yamabe H; Okumura K; Ishizaka H; Tsuchiya T; Yasue H
Am J Physiol; 1992 Jul; 263(1 Pt 2):H8-14. PubMed ID: 1636774
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-dependent regulation of coronary tone in the neonatal pig.
McGowan FX; Davis PJ; del Nido PJ; Sobek M; Allen JW; Downing SE
Anesth Analg; 1994 Dec; 79(6):1094-101. PubMed ID: 7978431
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
[TBL] [Abstract][Full Text] [Related]
9. Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.
Richard V; Berdeaux A; la Rochelle CD; Giudicelli JF
Br J Pharmacol; 1991 Sep; 104(1):59-64. PubMed ID: 1786519
[TBL] [Abstract][Full Text] [Related]
10. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation.
Gilligan DM; Panza JA; Kilcoyne CM; Waclawiw MA; Casino PR; Quyyumi AA
Circulation; 1994 Dec; 90(6):2853-8. PubMed ID: 7994830
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.
Cooper CJ; Landzberg MJ; Anderson TJ; Charbonneau F; Creager MA; Ganz P; Selwyn AP
Circulation; 1996 Jan; 93(2):266-71. PubMed ID: 8548898
[TBL] [Abstract][Full Text] [Related]
12. Role of nitric oxide in substance P-induced vasodilation differs between the coronary and forearm circulation in humans.
Tagawa T; Mohri M; Tagawa H; Egashira K; Shimokawa H; Kuga T; Hirooka Y; Takeshita A
J Cardiovasc Pharmacol; 1997 Apr; 29(4):546-53. PubMed ID: 9156366
[TBL] [Abstract][Full Text] [Related]
13. NG-monomethyl-L-ARG reduces the forearm vasodilator response to acetylcholine but not to methacholine in humans.
Rongen GA; Smits P; Thien T
J Cardiovasc Pharmacol; 1993 Dec; 22(6):884-8. PubMed ID: 7509909
[TBL] [Abstract][Full Text] [Related]
14. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
Quyyumi AA; Dakak N; Andrews NP; Husain S; Arora S; Gilligan DM; Panza JA; Cannon RO
J Clin Invest; 1995 Apr; 95(4):1747-55. PubMed ID: 7706483
[TBL] [Abstract][Full Text] [Related]
16. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries.
Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT
Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936
[TBL] [Abstract][Full Text] [Related]
17. Effect of cumulative doses of NG-nitro-L-arginine methyl ester on coronary blood flow of anesthetized and conscious dogs.
Matsunaga T; Okumura K; Ishizaka H; Tsunoda R; Yasue H
Arch Int Pharmacodyn Ther; 1994; 327(3):251-65. PubMed ID: 7848010
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs.
Canty JM; Schwartz JS
Circulation; 1994 Jan; 89(1):375-84. PubMed ID: 8281673
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of renal nitric oxide synthesis with NG-monomethyl-L-arginine and NG-nitro-L-arginine.
Naess PA; Kirkebøen KA; Christensen G; Kiil F
Am J Physiol; 1992 Jun; 262(6 Pt 2):F939-42. PubMed ID: 1535755
[TBL] [Abstract][Full Text] [Related]
20. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs.
Parent R; Paré R; Lavallée M
Am J Physiol; 1992 Jan; 262(1 Pt 2):H10-6. PubMed ID: 1733302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
